Abbott Ends US Sale, Distribution of Trifecta Aortic Valves
Abbott is ending sale and distribution of its Trifecta prosthetic valves in the United States “and will be removing the limited remaining inventory from the field,” the company announced Monday. The family of devices includes the Trifecta Valve, approved in 2011, and the Trifecta Valve with Glide Technology (Trifecta GT), on the US market since 2016. The move follows the […]
Continue reading »